SELDIFLEX LONG-TERM CENTRAL VENOUS CATHETER(40CM & 60CM IN LENGTH), MODELS 63244J20 & 63246J20

{0}------------------------------------------------ K992424 A. 510(k) Summary #### SUBMITTER: #### CONTACT PERSON: Plastimed Laboratoire Pharmaceutique Dr. Jean Daniel Nury B.P. 20 2 Rue Loues Armand Saint-Leu-La-Forêt Cédex 95321 France Ph: 011 33 134 44 15 15 Fax: 011 33 1 30 72 22 08 #### DATE PREPARED: TRADE NAME: NAME & NUMBER PREDICATE DEVICE(S): CLASSIFICATION PRODUCT CODE: June 11, 1999 DEC 2 9 2000 Seldiflex® central venous catheter Long-term intravascular catheter Unclassified Lis The Seldiflex® central venous catheter is substantially equivalent to the Hickman/Broviac central venous catheters manufactured by Bard Access Systems (K823553) and the ONECATH® long-term intravascular catheters manufactured by Luther Medical Products, Inc. (K980090), and other similar devices made by other manufacturers. ### DEVICE DESCRIPTION: The Seldiflex® is a single lumen, radiopaque polyurethane, long-term central venous catheter. Its accessories include a protective adapter female cap, introducer needle, needle obturator, double-ended J guidewire, scalpel, catheter clamp, rigid fastener, a vessel dilator, and silver Dacron® cuff. ## INTENDED USE: Plastimed's Seldiflex® central venous catheter is intended for long-term vascular access and is indicated for use with patients who require central venous pressure monitoring, I.V. fluids, blood products, drugs, or parenteral {1}------------------------------------------------ nutrition solutions. ## FUNCTIONAL & SAFETY TESTING: Functional and safety testing of the Seldiflex® central venous catheter consisted of examination of the function of the device under conditions similar to those found in normal usage and testing to ensure conformance to product specifications. The results of the examination and testing were successful, and did not raise any issues of safety and effectiveness of the device. ## CONCLUSION: The Seldiflex® central venous catheter is substantially equivalent to the Hickman/Broviac central venous catheters manufactured by Bard Access Systems (K823553) and the ONECATH® long-term intravascular catheters manufactured by Luther Medical Products, Inc. (K980090), and other similar devices made by other manufacturers based upon the devices' similarities in functional design, materials and indications for use. #### B. Truthful and Accurate Statement The Truthful and Accurate Statement is on the following page. {2}------------------------------------------------ ### DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes representing the department's mission. The eagle is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 DEC 2 9 2000 Mr. Jean-Daniel Nury General Manager Plastimed Laboratoire Pharmaceutiqu 95321 Saint-Lue-La-Foret Cedex, FRANCE K992424 Re : > Seldiflex® Central Catheter Trade Name: Requlatory Class: II Product Code: LJS Dated: October 6, 2000 October 10, 2000 Received: Dear Mr. Nury: We have reviewed your Section 510(k) notification of intent to we have reviewed referenced above and we have determined the marker is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, devices markees& In f the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). provibions or cho, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. ਚੋ substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 {3}------------------------------------------------ Page 2 - Mr. Nury through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations. This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Additionally, for questions on Compliance at (301) 594-4692. the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, Herald W. Sharp Timothy A. Ulatowski Director Division of Dental, Infection Control and General Hospital DEvices Office of Device Evaluation Center for Devices and Radioloqical Health Enclosure {4}------------------------------------------------ # INDICATIONS FOR USE PAGE 510(k) Number (if known): K992424 Device Name: Seldiflex® Central Venous Catheter INDICATIONS FOR USE: Plastimed's Seldiflex® central venous catheter is intended for long-term vascular access and is indicated for use with patients who require central venous pressure monitoring, I.V. fluids, blood products, drugs, or parenteral nutrition solutions. Concurrence of CDRH, Office of Device Evaluation (ODE) < Prescription Device Hevel W. Sheppard (Division Sign-Off) Division of Dental, Infection Control, and General Hospital Device F (Cik) Mumber . 510(k) Notification - Plastimed SELDIFLEX® Catheter June 1999 Page 1